Table 3.
Normalized relative expression of mRNA for paracrine factors.
| Normoxia | Hypoxia | |||
|---|---|---|---|---|
| 5% | 20% | 5% | 20% | |
| VEGF (n = 5) | 0.535 ± 0.038a | 0.667 ± 0.067 | 0.725 ± 0.051b | 0.812 ± 0.085 |
| MCP-1 (n = 5) | 1.162 ± 0.145 | 1.410 ± 0.231 | 0.259 ± 0.063b | 0.557 ± 0.214b |
| MIP-1α (n = 5) | 0.688 ± 0.042 | 0.757 ± 0.051 | 1.196 ± 0.136ab | 1.578 ± 0.061b |
| MIP-1β (n = 5) | 0.690 ± 0.069 | 0.600 ± 0.036 | 0.932 ± 0.101ab | 1.290 ± 0.127b |
| MMP-2 (n = 11) | 0.855 ± 0.039a | 0.583 ± 0.064 | 0.886 ± 0.066 | 0.718 ± 0.135 |
Data reported as mean ± SE. 5% and 20% refer to the amount of serum supplement present in the media. a P < 0.05 versus 20%; b P < 0.05 versus normoxia.